http://www.onemedplace.com/blog/wp-content/uploads/2009/04/heartsurgery.jpg
Symphony Medical, a developer of novel biopolymer technologies for cardiac disorders, has successfully used its flagship Algisyl-LVR technology to treat their first human patient.
View Articlehttp://www.onemedplace.com/blog/wp-content/uploads/2009/04/c-pulse_device_04s...
Sunshine Heart, a global company that develops cardiac assist devices, has successfully completed the first two implants of the company’s C-Pulse heart assist system under a 20-person clinical trial...
View Articlehttp://www.onemedplace.com/blog/wp-content/uploads/2009/04/backpain_11.jpg
ISTO Technologies has received FDA approval to begin a Phase I clinical study for NuQu, an injectable formulation of juvenile cartilage cells designed to treat chronic back pain caused by degenerative...
View Articlehttp://www.onemedplace.com/blog/wp-content/uploads/2009/04/doctorpatient.jpg
Researchers found that Dendreon’s immunotherapy drug Provenge prolonged the lives of advanced prostate cancer patients by an average of 4.1 months compared to a placebo.
View Articlehttp://www.onemedplace.com/blog/wp-content/uploads/2009/05/chemodrugs.jpg
A method of delivering chemotherapy drugs into a deadly type of brain tumor extended the lives of patients in early clinical trials.
View Articlehttp://www.onemedplace.com/blog/wp-content/uploads/2009/06/scale1.jpg
VIVUS, a pharmaceutical company specializing in products to treat sexual function, announced that their experimental obesity drug Qnexa was shown to improve blood sugar control in patients with type 2...
View Articlehttp://www.onemedplace.com/blog/wp-content/uploads/2009/06/depression.jpg
The money will allow CNS Response, based in Costa Mesa, Calif., to complete an upcoming depression study.
View Articlehttp://www.onemedplace.com/blog/wp-content/uploads/2009/07/conjunctivitis.jpg
FST-100 performed significantly better than other treatments for adenoviral conjunctivitis, including the current experimental "gold standard" topical cidofovir.
View Articlehttp://www.onemedplace.com/blog/wp-content/uploads/2009/07/knee.jpg
Cardiovascular Systems, a medical device company that specializes in the treatment of vascular diseases, has enrolled the first patient in its COMPLIANCE 360° clinical trial.
View Articlehttp://www.onemedplace.com/blog/wp-content/uploads/2010/11/blood-test-2.jpg
Scientists have yet to find the magic cure for cancer, but they may have found a way to beat it at its own game.
View ArticleMediTech Strategic Consultants B.V.: European Medical Devices Market...
MediTech Strategic Consultants B.V. (MediTech) is full service European Contract Research Organization (CRO) specializing in medical devices and combination products focused on Clinical, Regulatory and...
View ArticleVIDEO: Aptiv Solutions CEO Discusses Clinical Trials Guidelines, Unmet Need
Aside from re-defined financing structures, the most important issue facing life sciences EGCs is the need to increase clinical trial efficiency and productivity so that development budgets are used...
View ArticleRELEASE: Glysure Earns ISO 13485 Certification
GlySure Limited, developer of in-hospital continuous blood glucose monitoring systems, today announced that it has achieved ISO 13485 certification, the global standard for the requirements of a...
View ArticleAcadia Forges Forward With Pimavanserin
On March 12, 2013, Acadia Pharmaceuticals (ACAD) reported financial results for the fourth quarter and full year 2012. Total revenues in the quarter were $0.4 million, essentially in-line with our...
View Article
